Overview
- 156 inspections across 147 sites are on record.
- 395 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-03-10.
At a glance
Inspections
156
Sites
147
Observations
395
Career since
Aug 2010
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Lyne Laboratories, Inc. | 10 Mar 2026 | Human Drugs | On file |
| Cambridge Isotope Laboratories, Inc. | 29 Jan 2026 | Human Drugs | |
| Mart Specialities Lab LLP | 18 Nov 2025 | Human Drugs | On file |
| Divi's Laboratories Limited, Unit-1 | 14 Nov 2025 | Human Drugs | |
| ScieGen Pharmaceuticals India Private Limited | 7 Nov 2025 | Human Drugs |
Sites inspected
Lyne Laboratories, Inc.Brockton, United States1 insp.
Cambridge Isotope Laboratories, Inc.Andover, United States1 insp.
Mart Specialities Lab LLPMedchal Malkajgiri, India1 insp.
Divi's Laboratories Limited, Unit-1Nalgonda, India1 insp.
ScieGen Pharmaceuticals India Private LimitedMahabubnagar, India1 insp.
Co-investigators
Investigators who share inspections with this person.
Jonah S Ufferfilge5 shared
Nealie C Newberger5 shared
Daniel L Zheng4 shared
Erik W Koester4 shared
Edmund F Mrak4 shared
Sean R Marcsisin4 shared
Richard L Licari4 shared
Armen H Youssoufian2 shared
Margaret M Sands2 shared
Dien N Nguyen2 shared
Full investigator report
Get the verbatim findings behind Jonathan G Matrisciano's 395 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site